O'Sullivan JD - Search Results

1

A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease.

Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O'Sullivan JD, Fung V, Smith RA, Murphy MP, Taylor KM; Protect Study Group. Snow BJ, et al. Mov Disord. 2010 Aug 15;25(11):1670-4. doi: 10.1002/mds.23148. Mov Disord. 2010. PMID: 20568096 Clinical Trial.

2

Apomorphine-induced penile erections in Parkinson's disease.

O'Sullivan JD, Hughes AJ. O'Sullivan JD, et al. Mov Disord. 1998 May;13(3):536-9. doi: 10.1002/mds.870130326. Mov Disord. 1998. PMID: 9613749

3

Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.

O'Sullivan JD, Said CM, Dillon LC, Hoffman M, Hughes AJ. O'Sullivan JD, et al. Mov Disord. 1998 Nov;13(6):900-6. doi: 10.1002/mds.870130607. Mov Disord. 1998. PMID: 9827613

4

Yawning in Parkinson's disease.

O'Sullivan JD, Lees AJ, Hughes AJ. O'Sullivan JD, et al. Neurology. 1999 Jan 15;52(2):428. Neurology. 1999. PMID: 9932982 No abstract available.

5

Motor imagery in Parkinson's disease: a PET study.

Cunnington R, Egan GF, O'Sullivan JD, Hughes AJ, Bradshaw JL, Colebatch JG. Cunnington R, et al. Mov Disord. 2001 Sep;16(5):849-57. doi: 10.1002/mds.1181. Mov Disord. 2001. PMID: 11746614

6

Development and utilization of the patient knowledge questionnaire on botulinum toxin use in movement disorders.

Schoffer KL, O'Maley K, O'Sullivan JD. Schoffer KL, et al. J Clin Neurosci. 2007 Aug;14(8):737-41. doi: 10.1016/j.jocn.2006.03.021. Epub 2007 May 9. J Clin Neurosci. 2007. PMID: 17493818

7

Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.

Schoffer KL, Henderson RD, O'Maley K, O'Sullivan JD. Schoffer KL, et al. Mov Disord. 2007 Aug 15;22(11):1543-9. doi: 10.1002/mds.21428. Mov Disord. 2007. PMID: 17557339 Clinical Trial.

8

Current concepts in the management of Parkinson disease.

Hayes MW, Fung VS, Kimber TE, O'Sullivan JD. Hayes MW, et al. Med J Aust. 2010 Feb 1;192(3):144-9. doi: 10.5694/j.1326-5377.2010.tb03453.x. Med J Aust. 2010. PMID: 20121682 Review.

9

Anxiety disorders in Parkinson's disease: prevalence and risk factors.

Dissanayaka NN, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD. Dissanayaka NN, et al. Mov Disord. 2010 May 15;25(7):838-45. doi: 10.1002/mds.22833. Mov Disord. 2010. PMID: 20461800

10

The clinical spectrum of anxiety in Parkinson's disease.

Dissanayaka NN, White E, O'Sullivan JD, Marsh R, Pachana NA, Byrne GJ. Dissanayaka NN, et al. Mov Disord. 2014 Jul;29(8):967-75. doi: 10.1002/mds.25937. Mov Disord. 2014. PMID: 25043800 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters